top of page

Topic

Hematology-Oncology

2 Podcasts on BackTable

Hear how experienced clinicians in Hematology-Oncology approach day-to-day decision-making on BackTable. Learn from podcasts, cases, and courses curated by physician content creators. Get the BackTable app to follow this Topic and hear more of the conversations that matter to your practice.

Developing CAR T-Cell Programs in Community Oncology
00:00 / 01:04

Save your progress. Continue watching on the BackTable app.

BackTable Tumor Board

Episode # 78  •  25 Aug 2026

Developing CAR T-Cell Programs in Community Oncology

Where does access to cell therapy actually break down, and can community practices close the gap? On this episode of BackTable Tumor Board, host Aaron Lyss interviews Dr. Mike Byrne, a hematologist at Tennessee Oncology, about the challenges and successes of building an outpatient CAR T program in the community setting. They discuss the critical stakeholder relationships, operational and financial structures, and patient pathways that enable a physician-owned practice to offer cellular therapy outside a hospital system.

More on Hematology-Oncology

Loading recent podcasts…

Tumor Board

Tumor Board # 78

Aug 24, 2026

with Dr. Mike Byrne, Aaron Lyss

Developing CAR T-Cell Programs in Community Oncology

Where does access to cell therapy actually break down, and can community practices close the gap? On this episode of...

Tumor Board

Tumor Board # 54

Apr 6, 2026

with Dr. Tyler Stewart, Dr. Jun Gong

Clinical Advances in Muscle Invasive Bladder Cancer

Don’t miss the “curative window”! This episode takes a closer look at how evolving perioperative strategies and...

The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.

bottom of page